Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, Immediate Relatives of Designated Persons and Insiders (the Code), Divi’s Laboratories has informed that the Trading Window for dealing in securities of the Company will remain closed from April 01, 2026 till 48 hours after the declaration of audited financial results of the Company for the quarter and financial year ended March 31, 2026. The date of Board meeting for declaration of the audited financial results of the Company for the quarter and financial year ended March 31,2026, will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: